Failure of Etretinate in Epidermodysplasia verruciformis
- 1 January 1986
- journal article
- research article
- Published by S. Karger AG in Dermatology
- Vol. 173 (2) , 75-78
- https://doi.org/10.1159/000249222
Abstract
In a patient suffering from benign lesions of epidermodysplasia verruciformis due to human papillomavirus type 5 little clinical improvement could be observed after 6 months of oral etretinate. The drug was given 75 mg/day for 1 month before dosage was reduced to 50 mg/day. Control biopsy after 3 months of treatment still revealed large quantities of virions and typical cytopathic effects in light and electron microscopic examination.Keywords
This publication has 2 references indexed in Scilit:
- Epidermal changes induced by oral excess of aromatic retinoid in guinea pigsArchives of Dermatological Research, 1980
- Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformisProceedings of the National Academy of Sciences, 1978